ENDEFR
Home › Switzerland › ALEXION PHARMA GMBH

ALEXION PHARMA GMBH

Gesellschaft mit beschränkter Haftung (GmbH) · ZURICH, Switzerland · LEI DWCRFHBH0B4E23GPAD03
LEI lapsed

Summary

ALEXION PHARMA GMBH is registered in Switzerland and entered in the “Commercial Register” under number CHE-113.811.422. Its legal form is Gesellschaft mit beschränkter Haftung (GmbH) – private limited company (Switzerland). According to GLEIF, its ultimate parent is Alexion Pharmaceuticals, Inc. (United States). That group has 4 subsidiaries with LEIs in 4 countries, 1 of them in Switzerland. The LEI was first issued on 29 Nov 2012 and the record was last updated on 31 Jul 2023. It has lapsed: renewal was due by 17 Dec 2020. AssetCensus found 3 data-quality notes for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 17 Dec 2020 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2018, more than 24 months before this data release. The group may have changed since.
  • The ultimate-parent relationship record was not renewed; it was last updated on 31 Jul 2023.

Company details

Legal formGesellschaft mit beschränkter Haftung (GmbH)
private limited company (Switzerland)
RegisterCommercial Register · Register website
Registration numberCHE-113.811.422
Registration authorityMinistry of Justice
JurisdictionSwitzerland
Registered addressGIESSHÜBELSTRASSE 30, 8045 ZURICH, Switzerland
Categorycompany or other legal entity
Statusactive
LEIDWCRFHBH0B4E23GPAD03
LEI statuslapsed
LEI first issued29 Nov 2012
LEI record last updated31 Jul 2023
Next LEI renewal17 Dec 2020
Corroboration of the LEI recordfully corroborated

Group membership

Alexion Pharmaceuticals, Inc. United States lapsed ultimate parent
ALEXION PHARMA GMBH this entity
View the whole group: 4 subsidiaries in 4 countries

Relationship to the parent

Ultimate parent
ParentAlexion Pharmaceuticals, Inc.
Accounting period1 Jan 2018 to 31 Dec 2018
Evidenceconsolidated accounts
Corroborationfully corroborated
Accounting standardUS GAAP
Relationship start17 Dec 2019
Recorded at GLEIF since29 Nov 2012
Last updated31 Jul 2023
Record statusnot renewed

Parent not reported to GLEIF

  • Direct parent: the parent has no LEI and has not consented to obtain one.

Other names

  • Alexion Pharma International Sàrl · previous name